Nuvectis Pharma, Inc. Profile Avatar - Palmy Investing

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of var…

Biotechnology
US, Fort Lee [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Nuvectis Pharma, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Nuvectis Pharma, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Nuvectis Pharma, Inc..

End of NVCT's Analysis
CIK: 1875558 CUSIP: 67080T108 ISIN: US67080T1088 LEI: - UEI: -
Secondary Listings
NVCT has no secondary listings inside our databases.